451 related articles for article (PubMed ID: 35472088)
1. Clinical management of metastatic colorectal cancer in the era of precision medicine.
Ciardiello F; Ciardiello D; Martini G; Napolitano S; Tabernero J; Cervantes A
CA Cancer J Clin; 2022 Jul; 72(4):372-401. PubMed ID: 35472088
[TBL] [Abstract][Full Text] [Related]
2. Systemic treatment for metastatic colorectal cancer.
Leowattana W; Leowattana P; Leowattana T
World J Gastroenterol; 2023 Mar; 29(10):1569-1588. PubMed ID: 36970592
[TBL] [Abstract][Full Text] [Related]
3. The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer.
Taieb J; Jung A; Sartore-Bianchi A; Peeters M; Seligmann J; Zaanan A; Burdon P; Montagut C; Laurent-Puig P
Drugs; 2019 Sep; 79(13):1375-1394. PubMed ID: 31347092
[TBL] [Abstract][Full Text] [Related]
4. Current and evolving biomarkers for precision oncology in the management of metastatic colorectal cancer.
Henry JT; Johnson B
Chin Clin Oncol; 2019 Oct; 8(5):49. PubMed ID: 31500426
[TBL] [Abstract][Full Text] [Related]
5. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
6. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
[TBL] [Abstract][Full Text] [Related]
7. Current and future targets and therapies in metastatic colorectal cancer.
Dzunic M; Petkovic I; Cvetanovic A; Vrbic S; Pejcic I
J BUON; 2019; 24(5):1785-1792. PubMed ID: 31786838
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the recent developments in palliative chemotherapy for metastatic colorectal cancer.
Baek SK; Lee KT; Bae SB; Lee SC
Korean J Intern Med; 2019 Nov; 34(6):1188-1196. PubMed ID: 31346151
[TBL] [Abstract][Full Text] [Related]
9. Precision medicine for metastatic colorectal cancer: an evolving era.
Guler I; Askan G; Klostergaard J; Sahin IH
Expert Rev Gastroenterol Hepatol; 2019 Oct; 13(10):919-931. PubMed ID: 31475851
[No Abstract] [Full Text] [Related]
10. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
[TBL] [Abstract][Full Text] [Related]
11. Integrated approaches for precision oncology in colorectal cancer: The more you know, the better.
Andrei P; Battuello P; Grasso G; Rovera E; Tesio N; Bardelli A
Semin Cancer Biol; 2022 Sep; 84():199-213. PubMed ID: 33848627
[TBL] [Abstract][Full Text] [Related]
12. The emerging era of personalized medicine in advanced colorectal cancer.
Wu CWK; Reid M; Leedham S; Lui RN
J Gastroenterol Hepatol; 2022 Aug; 37(8):1411-1425. PubMed ID: 35815339
[TBL] [Abstract][Full Text] [Related]
13. Exploring biological heterogeneity and implications on novel treatment paradigm in BRAF-mutant metastatic colorectal cancer.
Rodriquenz MG; Ciardiello D; Latiano TP; Maiorano BA; Martinelli E; Silvestris N; Ciardiello F; Maiello E
Crit Rev Oncol Hematol; 2022 May; 173():103657. PubMed ID: 35337969
[TBL] [Abstract][Full Text] [Related]
14. [Personalized Treatment for Colorectal Carcinomas].
Stintzing S
Dtsch Med Wochenschr; 2017 Nov; 142(22):1652-1659. PubMed ID: 29078210
[TBL] [Abstract][Full Text] [Related]
15. Metastatic colorectal cancer- third line therapy and beyond.
Foo T; Roy A; Karapetis C; Townsend A; Price T
Expert Rev Anticancer Ther; 2024 May; 24(5):219-227. PubMed ID: 38526540
[TBL] [Abstract][Full Text] [Related]
16. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development.
Li X; Wu Y; Tian T
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430910
[TBL] [Abstract][Full Text] [Related]
17. The evolution of biomarkers to guide the treatment of metastatic colorectal cancer.
Davis LE
Am J Manag Care; 2018 Apr; 24(7 Suppl):S107-S117. PubMed ID: 30207665
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-guided therapy for colorectal cancer: strength in complexity.
Sveen A; Kopetz S; Lothe RA
Nat Rev Clin Oncol; 2020 Jan; 17(1):11-32. PubMed ID: 31289352
[TBL] [Abstract][Full Text] [Related]
19. Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.
Grothey A; Fakih M; Tabernero J
Ann Oncol; 2021 Aug; 32(8):959-967. PubMed ID: 33836264
[TBL] [Abstract][Full Text] [Related]
20. Strategic Insight into the Combination Therapies for Metastatic Colorectal Cancer.
Kano Y; Suenaga M; Uetake H
Curr Oncol; 2023 Jul; 30(7):6546-6558. PubMed ID: 37504340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
